A rare pitfall in the molecular interpretation of BRAF V600E status in melanoma in the setting of BRAF V600E‐mutated chronic lymphocytic leukemia/small lymphocytic lymphoma
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cutaneous Pathology"
DOI: 10.1111/cup.13440
Abstract: BRAF mutation status is a critical predictive and prognostic biomarker in guiding management of unresectable and metastatic melanoma.1 We recently observed a case of BRAF V600E-mutated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) intermixed with BRAF… read more here.
Keywords: status; braf v600e; melanoma; braf ... See more keywords
Clinical response to dabrafenib plus trametinib in BRAF V600E mutated papillary craniopharyngiomas: a case report and literature review
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2024.1464362
Abstract: Papillary craniopharyngiomas are rare tumors prevalent to the precision oncology world due to their high rate of BRAF V600E mutations. Symptoms include vision loss, neuroendocrine dysfunction, and cognitive dysfunction. Treatment involves an interdisciplinary approach with… read more here.
Keywords: braf v600e; mutated papillary; papillary craniopharyngiomas; v600e mutated ... See more keywords
Validation of Immunohistochemistry for the Detection of BRAF V600E-Mutated Lung Adenocarcinomas
Sign Up to like & getrecommendations! Published in 2019 at "Cancers"
DOI: 10.3390/cancers11060866
Abstract: BRAF V600E mutation, a missense mutation in exon 15 resulting in valine substitution for glutamate at position 600 within the kinase domain of BRAF oncogene, is found in a subset of lung adenocarcinoma (ADC). The… read more here.
Keywords: braf v600e; v600e mutated; v600e; mutated lung ... See more keywords